Home > Insider Trading > Kiniksa Pharmaceuticals International Plc

Kiniksa Pharmaceuticals International Plc (KNSA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to Kiniksa Pharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time all participants are in listen-only mode.

Keep Reading →

July 24th, 2024 - News Transcripts

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14.

Keep Reading →

April 24th, 2024 - News Transcripts

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call.

Keep Reading →

February 29th, 2024 - News Transcripts

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 1st, 2023 - News Transcripts

12 Cheap Biotech Stocks Smart Investors Are Piling Into

In this piece, we will take a look at 12 cheap biotechnology stocks that smart investors are piling into.

Keep Reading →

October 20th, 2023 - Hedge Funds News

25 Biggest Stocks with Negative Beta

Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.

Keep Reading →

September 29th, 2023 - Hedge Funds News

13 NASDAQ Stocks with Lowest PE Ratios That May Not Be Value Traps

In this piece, we will take a look at the 13 NASDAQ stocks with lowest PE ratios. If you want to skip our primer on one of the best performing U.S.

Keep Reading →

August 27th, 2023 - Hedge Funds News

11 Most Undervalued Biotech Stocks to Buy According to Analysts

In this article, we will take a look at the 11 most undervalued biotech stocks to buy according to analysts.

Keep Reading →

August 22nd, 2023 - Hedge Funds Industries News Stock Analysis

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

July 28th, 2023 - News Transcripts